Preliminary Analysis Shows Icosapent Ethyl Is Cost-Effective Treatment to Reduce Cardiovascular Risk in Patients with High Triglycerides
Icosapent ethyl is a cost-effective medical treatment to prevent cardiovascular events in patients with high triglyceride levels despite being on statin therapy with well-controlled low-density lipoprotein-cholesterol (LDL-C), according to a preliminary cost-effectiveness analysis to be presented at the American Heart Association’s Scientific Sessions 2019.